How can we help?
How can we help?
SCRI Oncology Partners
At SCRI Oncology Partners, we understand the challenges and fears that come with a cancer diagnosis. That’s why our compassionate team of globally-recognized oncologists in Tennessee is dedicated to transforming cancer care through a collaborative approach that puts you at the heart of everything we do. We believe that everyone facing cancer deserves access to the most advanced treatments, right in their own community. Our mission is to bring the latest in commercially available therapies, clinical trials and groundbreaking therapies directly to you, so you can receive the best possible care, close to home.
Cancers we treat
We partner with you based on your needs. Whether you’ve received a new diagnosis, are a previously-treated patient or are looking for additional opinions on cancer treatment and research, our physicians have decades of experience and are focused on providing top-notch care. Our globally-renowned oncologists specialize in treating:
- Blood cancers (leukemia, Hodgkin and non-Hodgkin lymphoma and myeloma)
- Breast cancer
- Central nervous system cancer
- Gastrointestinal cancer (colon, rectal, esophageal, gastric, liver, biliary, pancreatic)
- Genitourinary cancer (bladder, kidney, prostate, testicular/germ cell)
- Gynecologic cancer (ovarian, fallopian, uterine, cervical, vulvar)
- Head and neck cancer
- Lung cancer (non-small-cell, small-cell, mesothelioma)
- Melanoma (uveal, cutaneous, mucosal), basal cell, squamous
- Neuroendocrine and adrenal cancer
- Non-cancerous blood disorders (anemia, blood clotting disorders, hemophilia, thrombocytopenia)
- Sarcoma
- Thyroid
- And more
Find a Provider
SCRI Oncology Partners is led by experts with decades of experience
Specialties
Find out more about the cancers and disorders we treat
Clinical Trials
Access groundbreaking therapies and innovative treatments
Research
Our world-renowned experts specialize in comprehensive cancer care and are leading research on the latest cancer treatments and technologies. We leverage clinical trials to advance patient outcomes and consistently contribute to the field of cancer research. We conduct clinical trials through our affiliation with Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting community-based clinical trials. Since its inception more than 30 years ago, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the U.S. Food and Drug Administration (FDA) today.
Find out more about the work our oncologists are doing, and discover our research below.
Cancer Care Insights with SCRI Oncology Partners
Are you looking to understand more about your treatment options or your type of cancer? Maybe you’re a caregiver in search of valuable resources to better support your loved one? We have thoughtfully compiled a comprehensive collection of resources to provide you with detailed and useful information. You can explore all our resources, filter by category or search for exactly what you need. Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.
Six Must-Knows about Bladder Cancer
Bladder cancer is the fourth most common cancer diagnosed in men, and men are four times more likely than women to develop it.
What is Metastatic Breast Cancer?
Metastatic breast cancer is breast cancer that has spread from the breast to other parts of the body. This is also referred to as advanced or stage 4 breast cancer.
What is Biomarker Testing for Lung Cancer?
Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer, which may be tested for.
Press room
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Sarah Cannon Research Institute Appoints Director of Lymphoma Research
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
The US Oncology Network Further Expands Its Nashville, Tennessee Footprint and Research Expertise with the Addition of SCRI Oncology Partners
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
The US Oncology Network Further Expands Its Nashville, Tennessee Footprint and Research Expertise with the Addition of SCRI Oncology Partners
The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that SCRI Oncology Partners has joined The Network.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.
Contact Us
Whether you are newly diagnosed, previously treated or seeking additional care or research options, we are here to support you every step of the way.